BioMedomics Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$3.96M
- Investors
-
7
BioMedomics General Information
Description
Developer of a clinical diagnostics technology designed to detect diseases with its point-of-care products. The company's immunologically based, disease-specific technology and quantitative platforms are used to analyze cell-based assay procedures, enabling physicians to diagnose diseases and enhance patient outcomes.
Contact Information
Website
www.biomedomics.comCorporate Office
- 1100 Perimeter Park Drive
- Suite 104
- Morrisville, NC 27560
- United States
Corporate Office
- 1100 Perimeter Park Drive
- Suite 104
- Morrisville, NC 27560
- United States
BioMedomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 12-Nov-2025 | $3.96M | Completed | Generating Revenue | ||
| 6. Grant | 09-Aug-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B2) | 28-Jul-2017 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B1) | 12-Dec-2016 | Completed | Generating Revenue | |||
| 3. Debt - General | 04-Mar-2016 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 23-Feb-2015 | $276K | $966K | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 06-Jan-2014 | $690K | $690K | Completed | Generating Revenue |
BioMedomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series B | 922,737 | $0.001000 | $1.45 | $1.45 | 1x | $1.45 | 13.37% | |
| Series A | 1,293,750 | $0.001000 | $0.8 | $0.8 | 1x | $0.8 | 18.75% |
BioMedomics Comparisons
Industry
Financing
Details
BioMedomics Competitors (2)
One of BioMedomics’s 2 competitors is Hemex Health, a Venture Capital-Backed company based in Portland, OR.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hemex Health | Venture Capital-Backed | Portland, OR | ||||
| Micropoint | Formerly VC-backed | Santa Clara, CA |
BioMedomics Patents
BioMedomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2017139478-A1 | Devices systems and methods for quantifying hemoglobin s concentration | Inactive | 09-Feb-2016 | ||
| US-20190041407-A1 | Devices, systems and methods for quantifying hemoglobin s concentration | Inactive | 09-Feb-2016 | ||
| WO-2017062946-A1 | Lateral flow immunoassay devices, systems and methods for detecting α-thalassemia 1 trait southeast asian (sea) type | Inactive | 08-Oct-2015 | ||
| US-20160116489-A1 | Lateral flow immunoassay method of simultaneously detecting hemoglobin s, hemoglobin c, and hemoglobin a in newborns, infants, children, and adults | Pending | 23-Oct-2014 | ||
| US-20240361342-A1 | Lateral flow immunoassay method of simultaneously detecting hemoglobin s, hemoglobin c, and hemoglobin a in newborns, infants, children, and adults | Pending | 23-Oct-2014 | G01N33/721 |
BioMedomics Signals
BioMedomics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Government | |||
| National Cancer Institute | Government | |||
| National Heart, Lung, and Blood Institute | Government | |||
| National Institute on Drug Abuse (NIDA) | Government | |||
| NC Idea | Accelerator/Incubator |
BioMedomics FAQs
-
When was BioMedomics founded?
BioMedomics was founded in 2007.
-
Where is BioMedomics headquartered?
BioMedomics is headquartered in Morrisville, NC.
-
What is the size of BioMedomics?
BioMedomics has 14 total employees.
-
What industry is BioMedomics in?
BioMedomics’s primary industry is Diagnostic Equipment.
-
Is BioMedomics a private or public company?
BioMedomics is a Private company.
-
What is the current valuation of BioMedomics?
The current valuation of BioMedomics is .
-
What is BioMedomics’s current revenue?
The current revenue for BioMedomics is .
-
How much funding has BioMedomics raised over time?
BioMedomics has raised $2.25M.
-
Who are BioMedomics’s investors?
Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Cancer Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse (NIDA), and NC Idea are 5 of 7 investors who have invested in BioMedomics.
-
Who are BioMedomics’s competitors?
Hemex Health and Micropoint are competitors of BioMedomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process